What Researchers Did
Researchers reviewed the current understanding of methaemoglobinaemia, including its causes, how it affects the body, and available treatments.
What They Found
This review article found that methaemoglobinaemia, a condition where oxidized hemoglobin cannot carry oxygen, can cause severe hypoxemia and death, with patients typically asymptomatic at MetHb concentrations below 10%.
The condition can result from genetic mutations, inherited enzyme deficiencies, or exposure to oxidizing agents like dapsone and cocaine-derived anesthetics. While intravenous methylene blue is the primary treatment for symptomatic cases, other options include high-dose vitamin C, exchange transfusion, and potentially hyperbaric oxygen, though specific guidelines for HBOT use are lacking.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a review article, this study relies on existing literature and highlights the current lack of clear evidence and guidelines for the use of alternative therapies like hyperbaric oxygen in treating methaemoglobinaemia.